Breast cancer in the eastern province of Saudi Arabia

Medical Oncology

Volumn 15, Issue 4, 1998, Pages 241-247

  Ibrahim, Ezzeldin M ^a,b   Al Mulhim, Fatma A ^a   Al Amri, Ali ^a   Ai Muhanna, Fahd A ^a   Ezzat, Adnan A ^b   Stuart, Robert K ^b   Ajarim, Danish ^b  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Breast; Cancer; Kingdom of Saudi Arabia

Indexed keywords

ANTHRACYCLINE DERIVATIVE; TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PREMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAUDI ARABIA;

EID: 0032465059     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02787207     Document Type: Article

References (25)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics 1996. Ca-A Cancer J Clin 1996; 46: 5-27.
2. Parkin DM et al (Eds). Cancer Incidence in Five Continents. IARC: Lyon, 1992, vol 6, Scientific Publication 120.
3. Mahboubi E. Epidemiology of cancer in Saudi Arabia, 1975-1985. Ann Saudi Med 1987; 7: 265-276.
4. Ezzat A et al. An overview of breast cancer. Ann Saudi Med 1997; 17: 10-15.
5. Al-Tamimi T et al. Cancer in the Eastern Region of Saudi Arabia: a population-based study (1987-1988). Ann Saudi Med 1997; 17: 53-66.
6. Omer YT, Gjorgov AN, Ismail AS, Tabik MA. Cancer trends in Kuwait (1974-1982). In: M. Khogali, YT Omer, A Gjorgov, AS Ismail (eds). Cancer Prevention in Developing Countries Pergamon: London, 1986, p 25-34.
7. Ibrahim EM. Pattern and prognosis of breast cancer at a referral center in Saudi Arabia. Breast Dis 1990; 3: 187-198.
8. Ibrahim EM. Pattern and prognosis of breast cancer: data from the Eastern Province of Saudi Arabia. Saudi Med J 1991; 12: 227-231.
9. Harmanek P, Sobin LH. TNM Classification of Malignant Tumors. UICC International Union Against Cancer Springer-Verlag: Berlin, 1987.
10. American Joint Committee on Cancer. Manual for Staging of Cancer, 4th edn. Lippincott: Philadelphia, 1992, pp 149-154.
11. Haagensen CD, Stout AP. Carcinoma of the breast: Criteria of inoperability. Ann Surg 1943; 118: 859-870.
12. World Health Organization. Handbook for Reporting Results of Cancer Treatment WHO: Switzerland, 1979, no. 48, 16-21.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass 1958; 53: 457-481.
14. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1982; 38: 29-41.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
16. Cox DR, Oakes D. Regression models and life tables (with discussion). J Roy Stat Soc 1972; B34: 187-220.
17. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley: New York, 1980.
18. Kay R. Proportional hazard regression models and the analysis of censored survival data. Appl Stat 1977; 26: 227-237.
19. Dixon WJ, Brown MB, Engelman L, Jennrich RI. BMDP Statistical Software Manual. University of California Press: Berkeley, 1990.
20. Brufman G et al. Neoadjuvant chemotherapy (cyclophosphamide, adriamycin, and 5FU) for clinical Stage III breast cancer. Fourth International Congress on Anti-cancer Chemotherapy. 2-5 February 1993, Paris, p 58.
21. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 1-15.
22. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 71-85.
23. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 1995; 333: 1444-1455.
24. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998; 351: 1451-1466.
25. Saarto T, Blomqvist C, Groben P, Rissanen P, Elomaa I. The prognosis of stage III breast cancer treated with postoperative radiotherapy and adriamycin-based chemo-therapy with and without tamoxifen. Eight year follow-up results of a randomized trial. Eur J Surg Oncol 1995; 21: 146-150.